At Protagonist, patients and the communities in which we live and work are at the center of everything we do. Teams across our company engage collaboratively with external stakeholders on a range of long-term initiatives, including efforts to improve disease management and to ensure future access to our medicines.
We proudly advance education related to therapeutic areas in focus for our company. Our disease awareness campaigns help to educate the public about polycythemia vera and other diseases. We also support continuing medical education programs designed to inform healthcare providers of new scientific advances that can translate to new therapeutic options for patients.
We participate in major medical conferences, industry forums, and patient advocacy events as they take place around the world. In addition, we value opportunities to contribute to the exchange of scientific knowledge.
Advancing Scientific Progress
We value opportunities to connect with patients and caregivers who may one day benefit from the translation of science into approved interventions. In a given year, members of the Protagonist team can be found presenting the latest findings from our clinical studies, or walking side-by-side with patients to support rare disease awareness.
We are committed to making our treatments available to patients as quickly as possible for patients and to helping to advance clinical discovery in our areas of focus.
While patients are at the center of our corporate responsibility efforts, we recognize that operating in a sustainable manner benefits the environment and our stakeholders, including employees, investors, communities, and the patients we seek to serve.
Privacy Policy | Terms of Use | © 2024 Protagonist Therapeutics Inc. All Rights Reserved.
Spotlight, Arturo Molina, MD, Chief Medical Officer
At Protagonist, we work hard to meet the needs of the patient communities who are relying on us to innovate new and better medicines. Part of our commitment to them includes working to advance our medicines through clinical studies as quickly as possible and ensuring patients can access investigational therapies outside of our clinical trials, which has allowed some patients in critical need to access our therapies for several additional years after trials conclude.
Protagonist actively works to ensure we have strong patient representation in our clinical studies. We actively seek patients from across urban, suburban, and rural locations, from varying age groups and from among diverse backgrounds to ensure equitable patient representation in our study data.
We’re particularly concerned aging populations are left out of clinical studies, and we’re currently working to recruit older patients into our trials.
Spotlight: Carena Spivey, Head of HR
We view our diverse and welcoming corporate culture as being critical to our long-term success – It’s essential to the way we innovate. And we regularly track and report our progress, because we believe that what doesn’t get measured doesn’t get done.
Today:
- 65% of employees are members of underrepresented ethnic communities
- 51% are women
- nearly 50% of our Board identifies as a member of an underserved community or as female
We create the conditions for our employees to thrive, facilitating their learning and growth through a richly supportive workplace setting.
Part of that is creating a speak-up culture; we have cultivated an environment where every voice is heard, and we encourage the expression of different points of view in decision-making processes. At every turn, we encourage deep listening, thoughtful consideration, and open-mindedness that allows for decisions to be changed or refined in step with new data. By embracing our team members’ differences, we create wins for our organization and for patients.